← All trials
NCT04545541
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2020
- Primary completion
- Apr 30, 2022
- Completion date
- Jun 30, 2022
- First posted
- Sep 11, 2020
- Last posted
- Nov 17, 2020
- Enrollment
- 202
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Australian National UniversityLead sponsor
- Australian National UniversityStudy chair
- Australian National UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.